NCBI PubMed Central
open access
Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Caractérisation du rôle du régulateur épigénétique TRIM24 dans la plasticité de la cellule tumorale et la résistance aux thérapies dans le mélanome#301069
- GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma#833696
- Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment#837057
- DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma#1163803
- A Study of TRK-950 in Patients With Advanced Solid Tumors#1128125
Record · ID 1001159
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive